William E. Aliski's Insider Trades & SAST Disclosures

William E. Aliski's most recent trade in X4 Pharmaceuticals Inc was a trade of 45,000 Common Stock done . Disclosure was reported to the exchange on June 10, 2024.

Share

Note

This is a custom search result for pattern William E. Aliski.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
X4 Pharmaceuticals Inc	William E. Aliski	Director		10 Jun 2024	45,000	96,667 (0%)	0%		0	Common Stock
X4 Pharmaceuticals Inc	William E. Aliski	Director		06 Jun 2022	6,667	6,667 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ... Board Meeting	William E. Aliski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2021	4,125	4,125	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ... Board Meeting	William E. Aliski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2021	2,145	66,849 (0%)	0%		0	Common Stock
X4 Pharmaceuticals Inc	William E. Aliski	Director		02 Jun 2021	6,000	6,000	-		-	Stock Option (right to buy)
Ultragenyx Pharmaceutical ... Board Meeting	William E. Aliski	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	19 Feb 2021	7,500	0	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ... Board Meeting	William E. Aliski	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 97.85 per share.	19 Feb 2021	7,500	73,204 (0%)	0%	97.9	733,875	Common Stock
Ultragenyx Pharmaceutical ... Board Meeting	William E. Aliski	Director	Sale of securities on an exchange or to another person at price $ 149.01 per share.	19 Feb 2021	7,500	65,704 (0%)	0%	149.0	1,117,575	Common Stock
Ultragenyx Pharmaceutical ... Board Meeting	William E. Aliski	Director	Gift of securities by or to the insider at price $ 0.00 per share.	19 Feb 2021	1,000	64,704 (0%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades